ANS03

· Avistone Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANS03, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]